Cargando…

Impact of bilateral biopsy-detected prostate cancer on an active surveillance population

BACKGROUND: To assess factors that can predict active surveillance (AS) failure on serial transrectal ultrasound guided biopsies in patients with low-risk prostate cancer. METHODS: We evaluated the records of 144 consecutive patients enrolled in AS between 2007 and 2014 at a single academic institut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jonathan H., Sierra, Pablo, Richards, Kyle A., Abel, E. Jason, Allen, Glen O., Downs, Tracy M., Jarrard, David F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480830/ https://www.ncbi.nlm.nih.gov/pubmed/31014300 http://dx.doi.org/10.1186/s12894-019-0452-x

Ejemplares similares

Clinical and pathologic factors predicting reclassification in active surveillance cohorts
por: Sierra, Pablo S., et al.
Publicado: (2018)

Neutrophil to Lymphocyte Ratio (NLR) at the Time of Transurethral Resection of Bladder Tumor: A Large Retrospective Study and Analysis of Racial Differences
por: Tazeh, Ngii N., et al.
Publicado: (2017)

Surgical Operative Time Increases the Risk of Deep Venous Thrombosis and Pulmonary Embolism in Robotic Prostatectomy
por: Abel, E. Jason, et al.
Publicado: (2014)

Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy
por: Blute, Michael L., et al.
Publicado: (2017)

Validation of an epigenetic field of susceptibility to detect significant prostate cancer from non-tumor biopsies
por: Yang, Bing, et al.
Publicado: (2019)

Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection
por: Jarrard, William E., et al.
Publicado: (2019)

Step-by-Step: Fusion-guided prostate biopsy in the diagnosis and surveillance of prostate cancer
por: Nassiri, Nima, et al.
Publicado: (2019)

Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier
por: Etheridge, Tyler, et al.
Publicado: (2019)

Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs
por: Tomer, Anirudh, et al.
Publicado: (2019)

Biopsy interpretation of the prostate
por: Epstein, Jonathan I.

Prostate biopsy interpretation
por: Epstein, Jonathan I.

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
por: Andreas, Darian, et al.
Publicado: (2016)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Multiparametric-MRI and Targeted Biopsies in the Management of Prostate Cancer Patients on Active Surveillance
por: Sandler, Kiri, et al.
Publicado: (2015)

Risk of progression following a negative biopsy in prostate cancer active surveillance
por: Beckmann, Kerri, et al.
Publicado: (2022)

Case of bilateral hydronephrosis and spontaneous ureteral rupture as a rare complication of prostate biopsy
por: Korček, Michal, et al.
Publicado: (2022)

Characterization of prostate cancer detected at repeat biopsy
por: Yuasa, Takeshi, et al.
Publicado: (2008)

Characteristics of prostate cancer detection rate (PCDR) in Chinese Han population under different prostate biopsy methods
por: Pan, Yongsheng, et al.
Publicado: (2017)

Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance
por: Salguero, Joseba, et al.
Publicado: (2021)

Comparison of a Personalized Prostate Biopsy Pattern With Traditional Transrectal Prostate Biopsy: Different Cancer Detection Rate
por: Jiang, Xin, et al.
Publicado: (2022)

Magnetic Resonance Imaging–Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer
por: Jayadevan, Rajiv, et al.
Publicado: (2019)

Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non–Muscle-Invasive Bladder Cancer: Retrospective Cohort Study
por: Plasek, Joseph, et al.
Publicado: (2021)

Prostate biopsy approach and complication rates
por: Mate, Kinga, et al.
Publicado: (2023)

Does magnetic resonance imaging–guided biopsy improve prostate cancer detection? A comparison of systematic, cognitive fusion and ultrasound fusion prostate biopsy
por: Kam, Jonathan, et al.
Publicado: (2018)

Introduction of surgical site surveillance post transrectal ultrasound (TRUS) guided prostate biopsy and the impact on infection rates
por: Lenihan, Cian, et al.
Publicado: (2022)

Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer
por: Satyal, Uttam, et al.
Publicado: (2019)

Evaluating Surveillance Breast Imaging and Biopsy in Older Breast Cancer Survivors
por: Onega, Tracy, et al.
Publicado: (2012)

Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients
por: Mischinger, Johannes, et al.
Publicado: (2022)

Surveillance prostate biopsy utilizing piflufolastat F 18-PET/CT targeting in the intact prostate – A case report
por: Grossman, Tim, et al.
Publicado: (2023)

Incidental finding of extramammary Paget's disease during active surveillance for early‐stage prostate cancer in a prostate biopsy
por: Fujiwara, Kengo, et al.
Publicado: (2023)

The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend
por: Kim, Hyung-Sang, et al.
Publicado: (2012)

Confirmatory biopsy for the assessment of prostate cancer in men considering active surveillance: reference centre experience
por: Bosco, Cecilia, et al.
Publicado: (2016)

Effectiveness of Bi-Parametric MR/US Fusion Biopsy for Detecting Clinically Significant Prostate Cancer in Prostate Biopsy Naïve Men
por: Kim, Young Joo, et al.
Publicado: (2019)

Can we improve the detection rate of prostate cancer using standard 12‐core TRUS‐guided prostate biopsy? Focused on the location of prostate biopsy
por: Yoo, Sangjun, et al.
Publicado: (2020)

Red patches during bladder cancer surveillance: to biopsy or not to biopsy?
por: Drejer, Ditte, et al.
Publicado: (2018)

Analysis of Preoperative Detection for Apex Prostate Cancer by Transrectal Biopsy
por: Sazuka, Tomokazu, et al.
Publicado: (2013)

Current status of liquid biopsies for the detection and management of prostate cancer
por: Lu, Yi-Tsung, et al.
Publicado: (2019)

Optimal biopsy approach for detection of clinically significant prostate cancer
por: Ippoliti, Simona, et al.
Publicado: (2022)

The Role of TURP in the Detection of Prostate Cancer in BPH Patients with Previously Negative Prostate Biopsy
por: Kim, Dae Keun, et al.
Publicado: (2010)

Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
por: Pepe, Pietro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rbbqargpicvckt0s7pmfms5ep1